- Home
- DIT vs CRDL Comparison
DIT vs CRDL Comparison
Compare DIT & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- CRDL
- Stock Information
- Founded
- DIT 1981
- CRDL 2017
- Country
- DIT United States
- CRDL Canada
- Employees
- DIT N/A
- CRDL N/A
- Industry
- DIT Food Distributors
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIT Consumer Discretionary
- CRDL Health Care
- Exchange
- DIT Nasdaq
- CRDL Nasdaq
- Market Cap
- DIT 76.6M
- CRDL 90.4M
- IPO Year
- DIT 1995
- CRDL N/A
- Fundamental
- Price
- DIT $116.49
- CRDL $1.14
- Analyst Decision
- DIT
- CRDL Strong Buy
- Analyst Count
- DIT 0
- CRDL 2
- Target Price
- DIT N/A
- CRDL $9.00
- AVG Volume (30 Days)
- DIT 320.0
- CRDL 819.0K
- Earning Date
- DIT 11-07-2025
- CRDL 11-13-2025
- Dividend Yield
- DIT 0.86%
- CRDL N/A
- EPS Growth
- DIT N/A
- CRDL N/A
- EPS
- DIT 2.14
- CRDL N/A
- Revenue
- DIT $2,251,684,195.00
- CRDL N/A
- Revenue This Year
- DIT N/A
- CRDL N/A
- Revenue Next Year
- DIT N/A
- CRDL N/A
- P/E Ratio
- DIT $54.37
- CRDL N/A
- Revenue Growth
- DIT 7.64
- CRDL N/A
- 52 Week Low
- DIT $94.92
- CRDL $0.77
- 52 Week High
- DIT $163.75
- CRDL $2.24
- Technical
- Relative Strength Index (RSI)
- DIT 50.00
- CRDL 52.53
- Support Level
- DIT $113.11
- CRDL $1.14
- Resistance Level
- DIT $119.40
- CRDL $1.38
- Average True Range (ATR)
- DIT 2.60
- CRDL 0.08
- MACD
- DIT -0.16
- CRDL 0.01
- Stochastic Oscillator
- DIT 50.37
- CRDL 37.90
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.